|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/41 | |
| C07D 257/04 | |||
| C07C 233/47 |
| (11) | Number of the document | 3229799 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15843405.0 |
| Date of filing the European patent application | 2015-12-08 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/064432 |
| Date | 2015-12-08 |
| (87) | Number | WO 2016/049663 |
| Date | 2016-03-31 |
| (30) | Number | Date | Country code |
| 201462089225 P | 2014-12-08 | US |
| (72) |
CHEN, Minhua, US
ZHANG, Yanfeng, CN
YANG, Chaohui, CN
ZHANG, Xiaoyu, CN
LI, Jiaoyang, CN
WANG, Peng, US
LI, Pixu, CN
|
| (73) |
Crystal Pharmatech Co., Ltd.,
B4-101, Biobay, 218 Xinghu Street Suzhou Industrial Park, Suzhou, 215123,
CN
Suzhou Pengxu Pharmatech Co., Ltd., 3rd Floor, Building 7 2358 Changan Road Wujiang, Suzhou, 215200, CN |
| (54) | CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |
| CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |